TrialThe journal of extra-corporeal technology2024

Preliminary report of extracorporeal blood purification therapy in patients receiving LVAD: Cytosorb or Jafron HA330.

Zhuldyz Nurmykhametova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.